News

Addition to Scientific Advisory Board and Company Name Change

Posted on

Cambridge, UK, 14th August 2018 – Bactevo Ltd. announced today that Professor Pietro Lio of the Computer Laboratory in Cambridge University has joined its Scientific Advisory Board. Pietro brings a wealth of skills from the disciplines of bioinformatics and machine learning. During his distinguished career, Pietro has pioneered the development and testing of novel methodologies […]

News

Bactevo Enters Drug Discovery Agreement with Boehringer Ingelheim

Posted on

Cambridge UK, 2nd May 2018 – Bactevo Ltd. announced today that it has entered into a drug discovery collaboration agreement with Boehringer Ingelheim to identify novel small molecule lead compounds. This collaboration leverages Bactevo’s revolutionary TIME (Totally Integrated Medicines Engine) platform, incorporating its ground-breaking synthetic chemistry technology, designed specifically to combine medicinally-relevant ‘tagless’ chemical diversity […]

News

‘TIME’ featured in latest issue of Genetic Engineering & Biotechnology News

Posted on

Cambridge UK, 9th August 2017 – Bactevo’s Totally Integrated Medicines Engine (TIME) technology has been featured in the latest issue of Genetic Engineering & Biotechnology News (GEN). Click here to read the article. About Bactevo Bactevo has built a unique and game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Utilising its paradigm shift in the speed, efficiency […]

News

Bactevo unveils ‘TIME’ a novel, game-changing medicines discovery platform

Posted on

Achieves 100 Million Disease-Relevant Assays per Hour Incorporates Ground-Breaking Synthetic Chemistry Platform Management Team and SAB Expanded to Accelerate Next Phase of Growth 25th April, 2017 CAMBRIDGE, UK – Bactevo Ltd today unveiled a game-changing Totally Integrated Medicines Engine (TIME) capable of 100 million phenotypic assays per hour, a landmark in disease-relevant assay screening. TIME […]

News

Bactevo Wins Innovate Award

Posted on

Cambridge UK, 25th January 2017 – Bactevo, the revolutionary Cambridge, UK-based drug discovery company has received an Innovate Award for a prestigious £1.5M grant. Exploiting revolutionary work in the field of integrated, accelerated drug discovery in micro-droplets, Bactevo will progress its programmes focused on generating new antibiotic drugs to highly drug resistant Gram-negative pathogens causing septicaemia, chest […]

News

Drug Discovery Revolution- The Beginning?

Posted on

Bactevo are delighted to announce the date of September 28th, 2017 for the second ChemBioSphere meeting (entitled ChemBioSphere: Reprogramming Drug Discovery), following the enormous success of the inaugural meeting last week. Four one-day meetings will be held in successive years aimed at bringing together experts, change makers and decision leaders from every part of the […]

News

Bactevo Raises Financing for Synthetic Biology

Posted on

Cambridge UK, December 10th 2014 – Bactevo, the Industrial Biotechnology company, announced today that it has raised additional financing from New Wave Ventures LLP. The financing puts the company in an excellent position for ongoing and future commercial discussions. Bactevo is a Cambridge UK-based company utilising its proprietary molecular engineering technologies, known as TarGET, to […]

News

Bactevo Spins Off from Discuva

Posted on

Cambridge UK, 12th December 2012- Bactevo has spun-off from the antibiotics discovery company Discuva to develop its core technology expertise in the Industrial Biotechnology sector. Bactevo is a Cambridge UK-based company utilising its proprietary molecular engineering technologies, known as TarGET, to enable the use of bacteria for the synthesis of chemicals from sustainable resources. With […]